• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人血液系统恶性肿瘤伴发热性中性粒细胞减少症患者使用抗生素的时间与临床结局的关联

Association of time to antibiotics and clinical outcomes in adult hematologic malignancy patients with febrile neutropenia.

作者信息

Butts Allison R, Bachmeier Christina Carracedo, Dressler Emily V, Liu Meng, Cowden Ann, Talbert Jeff, Adams Val R

机构信息

1 Markey Cancer Center, University of Kentucky HealthCare, Lexington, KY, USA.

2 Department of Pharmacy, Lee Memorial Health System, Fort Myers, FL, USA.

出版信息

J Oncol Pharm Pract. 2017 Jun;23(4):278-283. doi: 10.1177/1078155216687150. Epub 2017 Jan 11.

DOI:10.1177/1078155216687150
PMID:28077045
Abstract

Objective The objective of this study was to determine the clinical impact of time to antibiotic administration in adult inpatients who have hematologic malignancies and develop febrile neutropenia. Methods A retrospective chart review was conducted to screen for all febrile neutropenia events amongst adult hematologic malignancy patients between 1 January 2010 and 1 September 2014. All included patients were admitted to the hospital at the time of fever onset, having been admitted for a diagnosis other than febrile neutropenia. Descriptive statistics and logistic generalized estimated equations were used to analyze the data. Results Two hundred forty-four neutropenic fever events met inclusion criteria. Thirty-five events (14.34%) led to negative clinical outcomes (in-hospital mortality, intensive care unit transfer, or vasopressor requirement), with an in-house mortality rate of 7.4%. The time to antibiotics ranged from 10 min to 1495 min. The median time to antibiotics in the events that led to negative outcomes was 120 min compared to 102 min in the events that did not lead to the negative outcome ( p = 0.93). Conditional order sets were used to order empiric antibiotics in 176 events (72.1%) and significantly reduced time to antibiotics from 287 min to 143 min ( p = 0.0019). Conclusion Prolonged time to antibiotic administration in hematologic malignancy patients who develop neutropenic fever was not shown to be associated with negative clinical outcomes.

摘要

目的 本研究的目的是确定抗生素给药时间对患有血液系统恶性肿瘤并发生发热性中性粒细胞减少症的成年住院患者的临床影响。方法 进行回顾性病历审查,以筛查2010年1月1日至2014年9月1日期间成年血液系统恶性肿瘤患者中的所有发热性中性粒细胞减少症事件。所有纳入患者在发热发作时入院,入院诊断不是发热性中性粒细胞减少症。使用描述性统计和逻辑广义估计方程分析数据。结果 244例中性粒细胞减少性发热事件符合纳入标准。35例事件(14.34%)导致不良临床结局(院内死亡、转入重症监护病房或需要血管升压药),院内死亡率为7.4%。抗生素给药时间为10分钟至1495分钟。导致不良结局的事件中抗生素给药的中位时间为120分钟,而未导致不良结局的事件中为102分钟(p = 0.93)。176例事件(72.1%)使用条件医嘱集开具经验性抗生素,显著缩短了抗生素给药时间,从287分钟降至143分钟(p = 0.0019)。结论 发生中性粒细胞减少性发热的血液系统恶性肿瘤患者抗生素给药时间延长未显示与不良临床结局相关。

相似文献

1
Association of time to antibiotics and clinical outcomes in adult hematologic malignancy patients with febrile neutropenia.成人血液系统恶性肿瘤伴发热性中性粒细胞减少症患者使用抗生素的时间与临床结局的关联
J Oncol Pharm Pract. 2017 Jun;23(4):278-283. doi: 10.1177/1078155216687150. Epub 2017 Jan 11.
2
Impact of time to antibiotic on hospital stay, intensive care unit admission, and mortality in febrile neutropenia.发热性中性粒细胞减少症中抗生素使用时间对住院时间、重症监护病房入住率和死亡率的影响。
Support Care Cancer. 2019 Nov;27(11):4171-4177. doi: 10.1007/s00520-019-04701-8. Epub 2019 Feb 25.
3
Extended follow-up of an antibiotic cycling program for the management of febrile neutropenia in a hematologic malignancy and hematopoietic cell transplantation unit.血液系统恶性肿瘤及造血干细胞移植科抗生素轮换方案用于发热性中性粒细胞减少症管理的长期随访
Transpl Infect Dis. 2013 Apr;15(2):142-9. doi: 10.1111/tid.12035. Epub 2012 Dec 20.
4
Outcomes Associated with De-escalation of Antibiotics to Target Positive Cultures when Treating Febrile Neutropenia.当治疗发热性中性粒细胞减少症时,针对阳性培养物降低抗生素剂量与结局的相关性。
J Pharm Pract. 2024 Apr;37(2):301-306. doi: 10.1177/08971900221132120. Epub 2022 Oct 6.
5
A retrospective analysis of clinical acuity markers on hospital length of stay in patients with febrile neutropenia.对发热性中性粒细胞减少症患者住院时间的临床严重程度标志物进行回顾性分析。
J Oncol Pharm Pract. 2019 Apr;25(3):535-543. doi: 10.1177/1078155217744379. Epub 2017 Dec 5.
6
Evaluation of imipenem 1.5 g daily in febrile patients with short duration neutropenia after chemotherapy for non-leukemic hematologic malignancies and solid tumors: personal experience and review of the literature.对非白血病血液系统恶性肿瘤和实体瘤化疗后短期中性粒细胞减少的发热患者每日使用1.5克亚胺培南的评估:个人经验及文献综述
Leuk Lymphoma. 2003 Apr;44(4):619-26. doi: 10.1080/1042819021000055309.
7
Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode.血液系统恶性肿瘤患者发热性中性粒细胞减少症中的继发感染:不止是又一次发热性中性粒细胞减少发作。
Turk J Haematol. 2015 Sep;32(3):243-50. doi: 10.4274/tjh.2013.0422.
8
Extended infusion compared to standard infusion cefepime as empiric treatment of febrile neutropenia.与标准输注头孢吡肟相比,延长输注作为发热性中性粒细胞减少症的经验性治疗。
J Oncol Pharm Pract. 2018 Apr;24(3):170-175. doi: 10.1177/1078155216687151. Epub 2017 Jan 11.
9
Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.黎巴嫩发热性中性粒细胞减少成年癌症患者中引起菌血症的第三代头孢菌素耐药肠杆菌科细菌和多重耐药革兰氏阴性菌、作为主要危险因素的广谱抗生素使用以及与预后不良的相关性
Front Cell Infect Microbiol. 2015 Feb 12;5:11. doi: 10.3389/fcimb.2015.00011. eCollection 2015.
10
The significance of serum urokinase plasminogen activation receptor (suPAR) in the diagnosis and follow-up of febrile neutropenic patients with hematologic malignancies.血清尿激酶型纤溶酶原激活物受体(suPAR)在血液恶性肿瘤发热性中性粒细胞减少症患者的诊断和随访中的意义。
Int J Infect Dis. 2013 Nov;17(11):e1056-9. doi: 10.1016/j.ijid.2013.04.004. Epub 2013 Jun 3.

引用本文的文献

1
Outcomes and microbiological patterns of bacteremia in chemotherapy-related febrile neutropenia at a tertiary facility in Kenya.肯尼亚一家三级医疗机构中化疗相关发热性中性粒细胞减少症患者菌血症的结局及微生物学特征
IJID Reg. 2025 Jul 18;16:100708. doi: 10.1016/j.ijregi.2025.100708. eCollection 2025 Sep.
2
Predicting chemotherapy toxicity in multiple myeloma: the prognostic value of pre-treatment serum cytokine levels of interleukin-6, interleukin-8, monocyte chemoattractant protein-1, and vascular endothelial growth factor.预测多发性骨髓瘤的化疗毒性:治疗前血清细胞因子白细胞介素-6、白细胞介素-8、单核细胞趋化蛋白-1 和血管内皮生长因子水平的预后价值。
Front Immunol. 2024 May 23;15:1377546. doi: 10.3389/fimmu.2024.1377546. eCollection 2024.
3
Impact of Time-to-Antibiotic Delivery in Pediatric Patients With Cancer Presenting With Febrile Neutropenia.癌症合并发热性中性粒细胞减少症患儿抗生素给药时间的影响。
JCO Oncol Pract. 2024 Feb;20(2):228-238. doi: 10.1200/OP.23.00583. Epub 2023 Dec 21.
4
Relationship Between the Use of Preprinted Physician Orders for Hospital-Acquired Fever and Time to Blood Culture Collection: A Single-Center Retrospective Cross-Sectional Study.医院获得性发热预印医生医嘱的使用与血培养采集时间的关系:一项单中心回顾性横断面研究。
Int J Gen Med. 2022 Jul 2;15:5929-5935. doi: 10.2147/IJGM.S361882. eCollection 2022.
5
Chemotherapy-Induced Neutropenia and Febrile Neutropenia in the US: A Beast of Burden That Needs to Be Tamed?美国的化疗所致中性粒细胞减少症和发热性中性粒细胞减少症:一种需要驯服的负担?
Oncologist. 2022 Aug 5;27(8):625-636. doi: 10.1093/oncolo/oyac074.
6
Factors and Outcomes Related to the Use of Guideline-Recommended Antibiotics in Patients With Neutropenic Fever at the Uganda Cancer Institute.乌干达癌症研究所中性粒细胞减少性发热患者使用指南推荐抗生素的相关因素及结果
Open Forum Infect Dis. 2021 Jun 10;8(7):ofab307. doi: 10.1093/ofid/ofab307. eCollection 2021 Jul.
7
Predictive Models of Fever, ICU Transfer, and Mortality in Hospitalized Patients With Neutropenia.中性粒细胞减少症住院患者发热、转入重症监护病房及死亡率的预测模型
Crit Care Explor. 2020 Dec 2;2(12):e0289. doi: 10.1097/CCE.0000000000000289. eCollection 2020 Dec.
8
Association of time to antibiotics and clinical outcomes in patients with fever and neutropenia during chemotherapy for cancer: a systematic review.癌症化疗期间发热伴中性粒细胞减少症患者使用抗生素的时间与临床结局的关系:系统评价。
Support Care Cancer. 2020 Mar;28(3):1369-1383. doi: 10.1007/s00520-019-04961-4. Epub 2019 Jul 1.
9
Impact of time to antibiotic on hospital stay, intensive care unit admission, and mortality in febrile neutropenia.发热性中性粒细胞减少症中抗生素使用时间对住院时间、重症监护病房入住率和死亡率的影响。
Support Care Cancer. 2019 Nov;27(11):4171-4177. doi: 10.1007/s00520-019-04701-8. Epub 2019 Feb 25.
10
Efficacy, safety and proper dose analysis of PEGylated granulocyte colony-stimulating factor as support for dose-dense adjuvant chemotherapy in node positive Chinese breast cancer patients.聚乙二醇化粒细胞集落刺激因子在支持中国淋巴结阳性乳腺癌患者进行剂量密集辅助化疗中的疗效、安全性及合适剂量分析
Oncotarget. 2017 May 24;8(45):80020-80028. doi: 10.18632/oncotarget.18145. eCollection 2017 Oct 3.